Skip to content

Coronavirus (COVID-19)

We have a number of temporary service changes in light of the Coronavirus pandemic. Temporary changes to our services.


We have a range of information and advice here: Coronavirus information.

Suffering anxiety, depression, low mood, stress?

We can help! Free, confidential NHS talking therapy service to help you. For more details visit Improving Access to Psychological Therapies.

Current research studies

Covid-19 research 

Psychological Impact of Coronavirus – pandemic and experience: An international survey [Second Phase of Recruitment]

Researchers from a collaboration group would like to invite you to take part in a short questionnaire exploring the psychological impact of the coronavirus, its effect on our emotions, behaviour and wellbeing. This is the second phase of recruitment. If you took part in the first phase of the study, you are still able to take part in this second phase, conversely if you did not take part in first phase; you are still able to take part in this second phase.

The aim of this survey is to better understand how the coronavirus pandemic and resultant restrictions/lockdown are affecting our day to day lifestyle. We hope to find out what is helpful for people during this time and also what may be causing some people to be affected more than others in terms of their wellbeing.

Anyone over the age of 16 with access to be able to complete this online questionnaire can take part. It is up to you to decide whether to take part or not. You are free to withdraw from the study at any time, without giving a reason and without consequence. This survey is completely voluntary, and you can stop completing it at any time. You also do not have to answer any questions you don’t want to; you can just skip them.

Want to find out more? Just click on this link

If you do complete the survey, please ensure that you select the Rotherham Doncaster and South Humber (RDaSH) NHS Foundation Trust from the drop-down list when answering where you heard about the study.’’

Phase 1 of the study took place April 2020 to July 2020 and a paper has been published on the data gathered during the first three weeks. To access the report please click here.


CO-CAT: Child Anxiety Treatment in the contact of Covid-19

What is this all about?

We are carrying out a study to compare a parent-led treatment which involves access to content on a website and with therapist support throughout for anxiety difficulties in children with the usual treatment that is currently being offered to treat child anxiety difficulties. The study is taking place across England, including in the clinical service that will be delivering your child’s treatment. If your child is eligible you will be told when they are referred into the service.

For more information please email:

Closes 26/02/2021



Platform Randomised trial of INterventions against COVID-19 in older peoPLE

This is a nationwide clinical trial from the University of Oxford to find COVID-19 treatments for the over 50s that can be taken at home.  The study is looking for medicines that can help people with COVID-19 symptoms get better quickly and stop them needing to go to hospital.

The trial is recruiting participants through its website and also through GP practices across the UK.


Oxford Vaccine Study – Phase 2

This study is seeking to recruit healthy volunteers based in or around the Sheffield area and over 55 years old.

For more information about the study please click here

Patient Information Sheet – 50 to 69 years C19 Oxford Phase 2 PIS 55 to 69 years

Patient Information Sheet – 70 years and over C19 Oxford Phase 2 PIS 70 years and over


Portfolio research 

Social Environment and Early Psychosis: An Urban Mind Study

The study is designed to help us understand how your social environment (e.g. who you are with) and stress affect mental wellbeing in the early stages of psychosis.

While most research on the social environment in people with psychosis has focused on specific features of the social environment, individual or environmental characteristics are rarely considered.  We will examine how individuals respond to the social environment by using a smartphone app called Urban Mind (see Urban Mind is an app that will measure experience of the social environment in the real time. The app uses Ecological Momentary Assessment (EMA) – a technique that involves multiple tests of how someone feels and what they do as they go about their daily life.

By collecting real-time data (information), we will be able to understand how ‘social stress sensitivity’ and ‘social withdrawal’ affect mental wellbeing and future mental health. The results of this study will be used to design and create a new smartphone app to predict the chance of relapse in patients with psychosis.

For more information please email:

Closes 30/09/2023


Hearing nasty voices: Developing new ways to measure the experience

This is part of a series of studies which are aiming to discover why negative and threatening voices (nasty voices) can be so believable and difficult to ignore.  By doing this, we hope that we can develop better psychological support for people who hear nasty voices.  One important area of this work is developing new ways to measure the experience of hearing nasty voices.  This study aims to develop two specific questionnaires:

  1. A questionnaire that measures the amount that people i) Believe the things that nasty voices say, ii) Listen to nasty voices.
  2. A questionnaire that measures the reasons why people listen and believe nasty voices.

To do this, we need to test which questions are the best questions to ask.  This is what this study is designed to find out.

For more information please email:

Closes 30/04/2021


Measuring outcomes of people with dementia and their carers

Researchers from the University of Kent are looking for study participants to help them understand how well social care services support people living with dementia and their family and friends, who support them.

Who do they need?

People living in England who are a family member or friend of someone living with dementia, who:

  • Lives at home (not in a nursing or residential care home)
  • Uses at least one type of social care service (e.g. home care, day activities)
  • Would not be able to answer a postal or online questionnaire, even with help.

What happens next?

If you decide to take part, you will be asked to complete a survey.  To request a copy of the survey, please email:

Study closing date: 31/03/2021


Da Vinci (Online Dementia Survey)

Hospital patients with symptoms of dementia or some other forms of cognitive impairment need additional support to manage a range of risks in hospital settings. Visual identification systems can be used as part of wider approaches to person-centred care to help staff to recognise patients with symptoms of dementia and to adapt their care accordingly.

We would like to ask you about your experiences of using visual identification systems to recognise hospital patients with symptoms of dementia. We are interested in your opinions about what works well, what does not work so well, and how to improve it.

Our aim is to better understand the different visual identification systems and to establish some principles that would lead to a system that works well for everyone: hospital patients with symptoms of dementia, their carer’s and advocates, and NHS staff who care for them.

The further information about the study, participant information sheet and survey link can be found here

Closing date: 31/03/2021


MH-CREST: Realist synthesis of community mental health crisis services

Mental health crises happen when people’s mental health gets worse and they need urgent support. Over recent years, community crisis care including Crisis and Home Treatment Teams has been developed. Many people are helped by crisis care but some reports show that this is not always the case. Crisis care services are often delivered by more than one organisation and it can be difficult for people to understand what each service offers. This study aims to explain how different types of crisis service work. We will do this using a ‘realist evidence synthesis.’ This is a type of research which tries to understand how services work in the real world. To do this we will review health policy, practice guidance, research and work with a group of experts. The experts will include mental health professionals, people with lived experience and carers. They will work with us to guide our research.

For more information please email:

Closing date: 31/04/2021


Genetic Links to Anxiety and Depression (GLAD) Study

This is led by the National Institute of Health Research (NIHR) Mental Health BioResource and researchers at King’s College London, in collaboration with researchers at Ulster University, University of Edinburgh and Cardiff University, is a project set up to support studies exploring risk factors for depression and/or anxiety.

Depression and anxiety are the most common mental health disorders worldwide.  In the UK, 1 in 3 people will experience symptoms during their lifetime.  The GLAD Study aims to better understand depression and anxiety in order to find effective treatments and improve the lives of people experiencing these disorders.

For more information and/or to take part in the study, please click the button below.

GLAD Study

Closing date: 31/03/2022


The CAP-MEM Study: Exploring the cause and prevalence of memory problems in mental health

It is known that many people with mental health, neurodevelopmental and neurodegenerative disorders have problems with memory and concentration. We do not understand why this happens.

The autonomic nervous system regulates the way that our heart, lungs and digestive system work. If these systems are not working in the usual way, then the blood supply to the brain will be slightly different. This change may be enough to affect memory and concentration.  We would like to know if the autonomic nervous system works differently in people with mental health, neurodevelopmental and neurodegenerative disorders. We would like to invite to the study people with and without such disorders to evaluate whether the autonomic nervous system is affected by the severity of the disorder or by medication use.

For more information please email:


The following studies are Sponsored by RDaSH and are delivered via GP Practices in Yorkshire and Humber

Clinical pharmacist eczema in children study

Patient education plays a key role in the successful management of atopic eczema. While Government policy supports the role of pharmacists in those with long-term conditions such as atopic eczema, there is only weak evidence that educational interventions by pharmacists can reduce the severity of eczema.

This study will investigate the impact on disease severity following an educational intervention provided by general medical practice-based, clinical pharmacists to parents/carers of children with atopic eczema. Parents of children aged between six months and six years of age will be invited to a consultation with the clinical practice-based pharmacist. During the consultation, pharmacists will assess parent/carer’s knowledge and understanding of Atopic Eczema and ask participants to complete a specific eczema disease severity tool. At a follow-up appointment, the pharmacists will re-check participant knowledge and understanding of eczema and repeat the eczema severity tool to assess for any changes.

The study has the potential to demonstrate the valuable contribution to care of patients with atopic eczema by practice-based pharmacists. If successful, the results would serve as an exemplar of best practice that can be more widely adopted within the NHS.

For more information please follow this link here.

or email:


The use of a screening tool in primary care to identify menopausal and perimenopausal women who could benefit from Hormone replacement therapy

The menopause represents a normal physiological change that occurs on average occurs in women age 50. Though not strictly an illness, the low levels of oestrogen associated with the menopause commonly results in symptoms such as hot flushes and night sweats. In addition, some also experience sleep disturbance, depression, mood changes, musculoskeletal pain, vaginal dryness and low libido. Hormone replacement therapy (HRT) is an effective treatment for menopausal symptoms but media reports of an increased risk of cancers have led to a decrease in the number of women using HRT despite the fact that symptoms can have a large and negative effect on quality of life. Participating in the study could involve a prescription of HRT, which is licensed for this purpose, as well as an assessment of the impact of this therapy using the two questionnaires.

The study has the potential to involve clinical practice-based pharmacists in the management of women with menopausal symptoms and to ensure that they are able to make an informed choice on the use of HRT and are managed in accordance with the NICE guideline.

For more information please follow this link here.

or email: